5-Aza-2'-deoxycytidine as a differentiation inducer in acute myeloid leukaemias and myelodysplastic syndromes of the elderly

Bone Marrow Transplant. 1989 Dec:4 Suppl 3:28-32.

Authors

A Pinto¹, V Zagonel, V Attadia, P L Bullian, V Gattei, A Carbone, S Monfardini, A Colombatti

Affiliation

¹ Leukemia Unit, C.R.O. Aviano, Italy.

PMID: 2483349

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Aged
Aged, 80 and over
Antineoplastic Agents / therapeutic use
Azacitidine / analogs & derivatives*
Azacitidine / therapeutic use
Bone Marrow / drug effects
Bone Marrow / pathology
Cell Differentiation / drug effects
Decitabine
Drug Evaluation
Female
Humans
Leukemia, Myeloid, Acute / drug therapy*
Leukemia, Myeloid, Acute / pathology
Male
Myelodysplastic Syndromes / drug therapy*
Myelodysplastic Syndromes / pathology
Neoplastic Stem Cells / drug effects
Neoplastic Stem Cells / pathology

Substances

Antineoplastic Agents
Decitabine
Azacitidine